Navigation Links
Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Date:11/13/2008

velopment, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

The Watson urology franchise is pleased to offer products and services that improve the quality of patients' lives, and satisfy the needs of physicians who specialize in the diagnosis, management, and treatment of urological disorders. By advancing education and support for urological diseases, we are creating the differences that make life more livable.

In the U.S., the Watson urology portfolio includes: RAPAFLO; Oxytrol(R); TRELSTAR(R) LA; TRELSTAR(R) Depot; Androderm(R); ProQuin(R) XR, under a co-promotion agreement with Depomed, Inc.; and AndroGel(R), under a co-promotion agreement with Solvay Pharmaceuticals, Inc. The Watson portfolio also includes a number of products under development including oxybutynin topical gel for overactive bladder and Uracyst(TM), for cystitis.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the impact of competitive products and pricing; market acceptance of and continued demand for Watson's products, including TRELSTAR; difficulties or delays in manufacturing; the difficulty of predicting the timing or outcome of FDA or other regulatory agency approvals or actions, if any; patents and other intellectual property rights he
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Watson Pharmaceuticals Reports Third Quarter 2008 Results
2. Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
3. Older Workers Worried About Promised Medicare and Social Security Benefits, Watson Wyatt Survey Finds
4. Watson Wyatt Identifies Trends for Benefits Open Enrollment Season
5. Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
6. Watson Announces Limited Recall of Fentanyl Transdermal System
7. Watson Launches Omeprazole Delayed-Release Capsules, 40MG
8. Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris
9. Watson Launches Generic MARINOL(R) Capsules
10. Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
11. Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... It is almost time to park your Hyundai to ... happier kids. The South Florida Hyundai Dealers Association is ... Children’s Hospital 5K Run/Walk. Its title sponsor is Hyundai ... 5K will take place on Saturday August 20th. The ... City Hall located at 405 Biltmore Way. Registration is ...
(Date:9/18/2014)... CRDF Global released today its 2013 ... – rich with videos, images and interactive graphics ... empowers scientists and innovators around the world. Working ... and individual supporters, CRDF Global reaches across borders ... and entrepreneurship. , The Annual Report highlights three ...
(Date:9/18/2014)... Clinical trial report, “Edema Global Clinical Trials Review, ... scenario. This report provides elemental information and data relating ... overview of the trial numbers and their recruitment status ... globe. The databook offers a preliminary coverage of disease ... the sponsors and also provides briefing pertaining to the ...
(Date:9/18/2014)... September 18, 2014 Research conducted by ... Allegheny Health Network has documented improved survival in ... removal of the tumors along with stereotactic radiosurgery. , ... ASTRO (American Society for Radiation Oncology) this ... numerous precisely focused radiation beams to treat tumors in ...
(Date:9/18/2014)... September 18, 2014 Good Neighbor ... launch of Good Neighbor Pharmacy University, an online ... that will educate and empower pharmacy owners and ... healthcare industry continues to evolve, Good Neighbor Pharmacy ... deliver resources and tools to help their businesses ...
Breaking Medicine News(10 mins):Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 3Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 3Health News:Good Neighbor Pharmacy University Keeps Pharmacists Ahead of the Curve 2
... on Hair Research will be convened in Vancouver from June ... experts, with clinicians and scientists examining many aspects of ... thin or thick, loosing hair can weaken a person emotionally. ... can also influence career advancement and emotional well being, adds ...
... , So shines a good deed in a weary world' ... is celebrated universally as the 'World Blood Donor Day' . It ... discovered the ABO blood group system. ,World ... Day, 2000, which was devoted to the theme 'Blood Saves Lives. ...
... Eraxis, known generically as anidulafungin was shown to be ... a potentially fatal blood infection seen in people ... to a research by Dr. Annette Reboli of Cooper ... published their findings in the New England Journal of ...
... help keep depression at bay. The study that was conducted ... up with the benefits of the major constituents of cod ... examining the dietary habits and health of about 22,000 subjects ... never took cod liver oil had higher rates of depression, ...
... alternative system of medicine, are continuing their protest here in ... ,The system treats diseases through the use of electricity. ... for over two months, complain that the authorities have not ... also want to meet Chief Minister Ghulam Nabi Azad with ...
... at the University of Virginia Health System have discovered ... restore hearing, into diseased tissue of the human inner ... curing genetic or acquired hearing loss. ,Dr. ... UVa, and his research team, including Dr. Bradley Kesser, ...
Cached Medicine News:Health News:World Largest Hair Congress Convene in Vancouver 2Health News:World Blood Donor Day 2Health News:New Anti Fungal Drug Eraxis as Good as the Older Medicine 2
(Date:9/18/2014)... , Sept. 18, 2014  KIYATEC announced today ... Small Business Innovation Research (SBIR) Phase II Contract ... the 27 institutes and centers that comprise the ... of the two year award, KIYATEC will expand ... issues at the forefront of cancer therapy strategies: ...
(Date:9/18/2014)... , Sept. 18, 2014  ADM Tronics Unlimited, ... , Ph.D. to its corporate Advisory Board for ... instructor at the Harvard Medical School and Visiting ... He received his Masters degree in Electronics Engineering ... from the University of Bologna. After spending a year ...
(Date:9/18/2014)... 18, 2014  Decision Resources Group finds that Regeneron,s ... (VEGF) agent for wet AMD, is equally likely to ... Genentech,s Lucentis, which is the standard of care for ... (MCO) directors do not identify a clear clinical or ... than Lucentis to be listed on tier 1 or ...
Breaking Medicine Technology:National Cancer Institute Awards KIYATEC Nearly $2M to Advance Predictive Cancer Diagnostics 2National Cancer Institute Awards KIYATEC Nearly $2M to Advance Predictive Cancer Diagnostics 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3
Inquire...
Inquire...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
Medicine Products: